UA69673U - method for correction of cellular immunity in patients with firstly diagnosed pulmonary tuberculosis caused by polyantibiotic-resistant strains of the causative agent of tuberculosis - Google Patents

method for correction of cellular immunity in patients with firstly diagnosed pulmonary tuberculosis caused by polyantibiotic-resistant strains of the causative agent of tuberculosis

Info

Publication number
UA69673U
UA69673U UAU201112342U UAU201112342U UA69673U UA 69673 U UA69673 U UA 69673U UA U201112342 U UAU201112342 U UA U201112342U UA U201112342 U UAU201112342 U UA U201112342U UA 69673 U UA69673 U UA 69673U
Authority
UA
Ukraine
Prior art keywords
tuberculosis
polyantibiotic
patients
correction
resistant strains
Prior art date
Application number
UAU201112342U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Юрий Григорьевич Пустовой
Валерий Митрофанович Фролов
Галина Николаевна Роенко
Наталия Анатолиевна Грицова
Евгений Дмитриевич Андросов
Original Assignee
Юрий Григорьевич Пустовой
Валерий Митрофанович Фролов
Галина Николаевна Роенко
Наталия Анатолиевна Грицова
Евгений Дмитриевич Андросов
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Юрий Григорьевич Пустовой, Валерий Митрофанович Фролов, Галина Николаевна Роенко, Наталия Анатолиевна Грицова, Евгений Дмитриевич Андросов filed Critical Юрий Григорьевич Пустовой
Priority to UAU201112342U priority Critical patent/UA69673U/en
Publication of UA69673U publication Critical patent/UA69673U/en

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

A method for correction of cellular immunity in patients with firstly diagnosed pulmonary tuberculosis caused by polyantibiotic-resistant strains of the causative agent of tuberculosis comprises the administration of Nucleinate immunoactive drug.
UAU201112342U 2011-10-21 2011-10-21 method for correction of cellular immunity in patients with firstly diagnosed pulmonary tuberculosis caused by polyantibiotic-resistant strains of the causative agent of tuberculosis UA69673U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201112342U UA69673U (en) 2011-10-21 2011-10-21 method for correction of cellular immunity in patients with firstly diagnosed pulmonary tuberculosis caused by polyantibiotic-resistant strains of the causative agent of tuberculosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201112342U UA69673U (en) 2011-10-21 2011-10-21 method for correction of cellular immunity in patients with firstly diagnosed pulmonary tuberculosis caused by polyantibiotic-resistant strains of the causative agent of tuberculosis

Publications (1)

Publication Number Publication Date
UA69673U true UA69673U (en) 2012-05-10

Family

ID=52297086

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201112342U UA69673U (en) 2011-10-21 2011-10-21 method for correction of cellular immunity in patients with firstly diagnosed pulmonary tuberculosis caused by polyantibiotic-resistant strains of the causative agent of tuberculosis

Country Status (1)

Country Link
UA (1) UA69673U (en)

Similar Documents

Publication Publication Date Title
HK1193813A1 (en) Pharmaceutically active disubstituted pyridine derivatives
EP2729109A4 (en) Chair, frame and lifting garment useful for patients
MX337193B (en) Dialysis machine support assemblies and related systems and methods.
MX357598B (en) Intravaginal devices for drug delivery.
MX2013012542A (en) Amide compound and pharmaceutical application therefor.
TW201144301A (en) Processes for preparing linezolid
PH12015502178A1 (en) Pyridinylpyrazoloquinoline compound
MX359825B (en) Pyrazole compound and use thereof for medical purposes.
MX356801B (en) Increasing drug bioavailability in naltrexone therapy.
HK1201150A1 (en) Scheme for administering n-hydroxy-4-2-[3-(n,n- dimethylaminomethyl)benzofuran-2-ylcarbonylamino]ethoxybenzamide n--4-2-[3-(n,n-)-2-]
BR112015002123A2 (en) infusion set for a beverage preparation machine using capsules and the like
MX350718B (en) Equine rhinitis vaccine.
PH12014501384A1 (en) Antibiotic formulations
UA69673U (en) method for correction of cellular immunity in patients with firstly diagnosed pulmonary tuberculosis caused by polyantibiotic-resistant strains of the causative agent of tuberculosis
UA58750U (en) method for correction of immunity cell link indices in patients with the lung tuberculosis diagnosed for the first time, caused by polyantibiotic-resistant tuberculosis strains
UA70710U (en) Method for preventing recurrence of allergodermatosis in patients with secondary immunodeficiencies
UA69679U (en) method for correction of the functional status of phagocytic macrophages in patients with syndrome of emotional burnout
UA55591U (en) method for correction of indices of cellular immunity unit in patients with firstly diagnosed pulmonary tuberculosis, caused by polyantibiotic-resistant strains of tuberculosis pathogen
CO7091173A2 (en) Sildenafil orodispersible tablet and method to prepare it
UA69975U (en) Method for correction of cellular immunity in patients with nonalcoholic steatohepatitis
UA35028U (en) Method for correcting functional state of macrophage-phagocyte system in patients with newly diagnosed pulmonary tuberculosis caused by multiresistant strains of mycobacterium
UA65038U (en) method for treatment of patients with tocomanias
UA69684U (en) method for rehabilitation of patients with nonalcoholic steatohepatitis, combined with intestinal dysbiosis
UA62373U (en) Method for correcting vegetative dysfunction in patients with chemoresistant pulmonary tuberculosis
UA64828U (en) method for medical rehabilitation of adult patients with somatized disorders